Related references
Note: Only part of the references are listed.Hepatitis B Virus-Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma
Karen Man-Fong Sze et al.
HEPATOLOGY (2021)
Bi-allelic Variants in RALGAPA1 Cause Profound Neurodevelopmental Disability, Muscular Hypotonia, Infantile Spasms, and Feeding Abnormalities
Matias Wagner et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2020)
Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential
Yu-Man Tsui et al.
BRITISH JOURNAL OF CANCER (2020)
Down-regulation of RalGTPase-Activating Protein Promotes Colitis-Associated Cancer via NLRP3 Inflammasome Activation
Tomoya Iida et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2020)
Ral GTPase Activation by Downregulation of RalGAP Enhances Oral Squamous Cell Carcinoma Progression
P. Gao et al.
JOURNAL OF DENTAL RESEARCH (2019)
RaIA controls glucose homeostasis by regulating glucose uptake in brown fat
Yuliya Skorobogatko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
TSC1/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication
Daniel W. H. Ho et al.
GUT (2017)
Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice
Chun-Qing Song et al.
GASTROENTEROLOGY (2017)
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Adrian Ally et al.
CELL (2017)
INSECT 2.0: a web-server for genome-wide cis-regulatory modules prediction
R. Gonzalo Parra et al.
BIOINFORMATICS (2016)
Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells
Xiaofang Sun et al.
HEPATOLOGY (2016)
Two-Step Forward Genetic Screen in Mice Identifies Ral GTPase-Activating Proteins as Suppressors of Hepatocellular Carcinoma
Takahiro Kodama et al.
GASTROENTEROLOGY (2016)
Plant GSTome: structure and functional role in xenome network and plant stress response
Nikolaos E. Labrou et al.
CURRENT OPINION IN BIOTECHNOLOGY (2015)
Ral GTPases: crucial mediators of exocytosis and tumourigenesis
Ryutaro Shirakawa et al.
JOURNAL OF BIOCHEMISTRY (2015)
Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor Everolimus
Hung Huynh et al.
MOLECULAR CANCER THERAPEUTICS (2015)
GARNL1, a major RalGAP α subunit in skeletal muscle, regulates insulin-stimulated RalA activation and GLUT4 trafficking via interaction with 14-3-3 proteins
Qiaoli Chen et al.
CELLULAR SIGNALLING (2014)
Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma
Bo Zhai et al.
MOLECULAR CANCER THERAPEUTICS (2014)
RalA signaling pathway as a therapeutic target in hepatocellular carcinoma (HCC)
Mohamad Ezzeldin et al.
MOLECULAR ONCOLOGY (2014)
Discovery and characterization of small molecules that target the GTPase Ral
Chao Yan et al.
NATURE (2014)
Ral GTPases in tumorigenesis: Emerging from the shadows
David F. Kashatus
EXPERIMENTAL CELL RESEARCH (2013)
Akt and mTORC1 Have Different Roles During Liver Tumorigenesis in Mice
Heidi L. Kenerson et al.
GASTROENTEROLOGY (2013)
Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer
R. Saito et al.
ONCOGENE (2013)
Inhibition of RalA signaling pathway in treatment of non-small cell lung cancer
Heather Male et al.
LUNG CANCER (2012)
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
Cecile Guichard et al.
NATURE GENETICS (2012)
Different metastasis promotive potency of small G-proteins RalA and RalB in in vivo hamster tumor model
Vera A. Rybko et al.
CANCER CELL INTERNATIONAL (2011)
Activation and Involvement of Ral GTPases in Colorectal Cancer
Timothy D. Martin et al.
CANCER RESEARCH (2011)
Tuberous Sclerosis Tumor Suppressor Complex-like Complexes Act as GTPase-activating Proteins for Ral GTPases
Ryutaro Shirakawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma
Wen Xue et al.
GENES & DEVELOPMENT (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Hyperactive Ras in developmental disorders and cancer
Suzanne Schubbert et al.
NATURE REVIEWS CANCER (2007)
Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells
Kian-Huat Lim et al.
CURRENT BIOLOGY (2006)
The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer
SC Smith et al.
CANCER RESEARCH (2006)
RalA and RalB: Antagonistic relatives in cancer cell migration
G Oxford et al.
CANCER RESEARCH (2005)
Activation of RaIA is critical for Ras-induced tumorigenesis of human cells
KH Lim et al.
CANCER CELL (2005)
RalA interacts with ZONAB in a cell density-dependent manner and regulates its transcriptional activity
P Frankel et al.
EMBO JOURNAL (2005)
The small-GTPase RalA activates transcription of the urokinase plasminogen activator receptor (uPAR) gene via an AP1-dependent mechanism
E Okan et al.
ONCOGENE (2001)
Share Paper
